Items home
EnglishFrenchDutchSpanishGermanItalianChineseTurkishPolish

Programmi di VEQ

Di seguito è riportata una lista campione di programmi di VEQ molecolari. Per ulteriori informazioni o per registrarsi ad un programma di VEQ procedete entrando nella vostra pagina di "Profilo del partecipante".Se non avete un identificativo (username) e una password cliccate qui .

Blood Borne Virus
Click to view / hide
B19 virus
Feature
Available Format(s)
Catalogue Number
QAV034116_1 QAV034116_2
Total Number of Challenges
1 2
Number of Panel Members
8 4 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
HBV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV124160_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
HBV Genotyping
Feature
Available Format(s)
Catalogue Number
QAV064118_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q1
HCV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV134167_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
HCV Genotyping
Feature
Available Format(s)
Catalogue Number
QAV034117_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q1
Hepatitis A virus
Feature
Available Format(s)
Catalogue Number
QAV124156_1 QAV124156_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 10 4 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Hepatitis B virus
Feature
Available Format(s)
Catalogue Number
QAV994110_1 QAV994110_2 QAV994110_4
Total Number of Challenges
1 2 4
Number of Panel Members
8 4 per challenge 4 per challenge
Distribution / Testing Period
Q3 Q1 & Q3 Q1,Q2,Q3 & Q4
Hepatitis C virus
Feature
Available Format(s)
Catalogue Number
QAV994112_1 QAV994112_2 QAV994112_4
Total Number of Challenges
1 2 4
Number of Panel Members
8 4 per challenge 4 per challenge
Distribution / Testing Period
Q3 Q1 & Q3 Q1,Q2,Q3 & Q4
Hepatitis D virus
Feature
Available Format(s)
Catalogue Number
QAV144170_1
Total Number of Challenges
1
Number of Panel Members
8 to 10
Distribution / Testing Period
Q3
Hepatitis E virus
Feature
Available Format(s)
Catalogue Number
QAV124157_1
Total Number of Challenges
1
Number of Panel Members
8 to 10
Distribution / Testing Period
Q3
HIV-1 (DNA)
Feature
Available Format(s)
Catalogue Number
QAV034114_1 QAV034114_2
Total Number of Challenges
1 2
Number of Panel Members
8 4 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
HIV-1 (RNA)
Feature
Available Format(s)
Catalogue Number
QAV994108_1 QAV994108_2 QAV994108_4
Total Number of Challenges
1 2 4
Number of Panel Members
8 4 per challenge 4 per challenge
Distribution / Testing Period
Q3 Q1 & Q3 Q1,Q2,Q3 & Q4
HIV-1 Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV024131_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
HIV-1 Drug Resistance (Integrase)
Feature
Available Format(s)
Catalogue Number
QAV114146_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
Central Nervous System
Click to view / hide
BK virus
Feature
Available Format(s)
Catalogue Number
QAV144166_1 QAV144166_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Borrelia burgdorferi spp. (Lyme Disease)
Feature
Available Format(s)
Catalogue Number
QAB114147_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Chikungunya virus
Feature
Available Format(s)
Catalogue Number
QAV154175_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Central Nervous System I (Viral)
Feature
Available Format(s)
Catalogue Number
QAV174195_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Central Nervous System II (Non-Viral)
Feature
Available Format(s)
Catalogue Number
QAM174196_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Dengue virus
Feature
Available Format(s)
Catalogue Number
QAV114148_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Enterovirus
Feature
Available Format(s)
Catalogue Number
QAV984104_1 QAV984104_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Enterovirus Typing
Feature
Available Format(s)
Catalogue Number
QAV164185_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q1
Herpes Simplex virus 1 & 2
Feature
Available Format(s)
Catalogue Number
QAV994105_1 QAV994105_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Herpes Simplex virus drug resistance
Feature
Available Format(s)
Catalogue Number
QAV164184_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q1
JC virus
Feature
Available Format(s)
Catalogue Number
QAV074106_1 QAV074106_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Measles / Mumps
Feature
Available Format(s)
Catalogue Number
QAV144171_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Parechovirus
Feature
Available Format(s)
Catalogue Number
QAV114145_1 QAV114145_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Toxoplasma gondii
Feature
Available Format(s)
Catalogue Number
QAP044123_1 QAP044123_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Varicella-Zoster virus
Feature
Available Format(s)
Catalogue Number
QAV034103_1 QAV034103_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
West Nile virus
Feature
Available Format(s)
Catalogue Number
QAV104141_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Zika virus
Feature
Available Format(s)
Catalogue Number
QAV164186_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Congenital Infections
Click to view / hide
Cytomegalovirus Dried Blood Spots
Feature
Available Format(s)
Catalogue Number
QAV064127_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Toxoplasma gondii
Feature
Available Format(s)
Catalogue Number
QAP044123_1 QAP044123_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Drug Resistance
Click to view / hide
CMV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV144169_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q2
Extended Spectrum ß-lactamase and Carbapenemase
Feature
Available Format(s)
Catalogue Number
QAB134162_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
HBV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV124160_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
HCV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV134167_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
Herpes Simplex virus drug resistance
Feature
Available Format(s)
Catalogue Number
QAV164184_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q1
HIV-1 Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV024131_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
HIV-1 Drug Resistance (Integrase)
Feature
Available Format(s)
Catalogue Number
QAV114146_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
Methicillin Resistant Staphylococcus aureus
Feature
Available Format(s)
Catalogue Number
QAB064124_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Vancomycin Resistant Enterococci
Feature
Available Format(s)
Catalogue Number
QAB134163_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Exotic / Emerging Diseases
Click to view / hide
Chikungunya virus
Feature
Available Format(s)
Catalogue Number
QAV154175_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Dengue virus
Feature
Available Format(s)
Catalogue Number
QAV114148_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
MERS Coronavirus
Feature
Available Format(s)
Catalogue Number
QAV154181_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q2
West Nile virus
Feature
Available Format(s)
Catalogue Number
QAV104141_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Zika virus
Feature
Available Format(s)
Catalogue Number
QAV164186_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Gastrointestinal Diseases
Click to view / hide
Adenovirus
Feature
Available Format(s)
Catalogue Number
QAV054133_1 QAV054133_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Bacterial Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAB124153_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Clostridium difficile
Feature
Available Format(s)
Catalogue Number
QAB084125_1 QAB084125_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Diarrheagenic Escherichia coli
Feature
Available Format(s)
Catalogue Number
QAB154179_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Helicobacter pylori
Feature
Available Format(s)
Catalogue Number
QAB164190_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q3
Norovirus
Feature
Available Format(s)
Catalogue Number
QAV084139_1 QAV084139_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Parasitic Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAP124154_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Viral Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAV124152_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Immunocompromised Associated Diseases
Click to view / hide
Aspergillus spp.
Feature
Available Format(s)
Catalogue Number
QAF104140_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
BK virus
Feature
Available Format(s)
Catalogue Number
QAV144166_1 QAV144166_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Candida spp.
Feature
Available Format(s)
Catalogue Number
QAF124151_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
CMV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV144169_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q2
Cytomegalovirus Whole Blood
Feature
Available Format(s)
Catalogue Number
QAV124150_1 QAV124150_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Epstein-Barr virus
Feature
Available Format(s)
Catalogue Number
QAV024121_1 QAV024121_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Epstein-Barr virus Whole Blood
Feature
Available Format(s)
Catalogue Number
QAV134161_1 QAV134161_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Human Cytomegalovirus
Feature
Available Format(s)
Catalogue Number
QAV014120_1 QAV014120_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Human Herpes virus 6
Feature
Available Format(s)
Catalogue Number
QAV084119_1 QAV084119_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Immunocompromised
Feature
Available Format(s)
Catalogue Number
QAM174197_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
JC virus
Feature
Available Format(s)
Catalogue Number
QAV074106_1 QAV074106_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Pneumocystis jirovecii pneumonia (PCP)
Feature
Available Format(s)
Catalogue Number
QAF114144_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Toxoplasma gondii
Feature
Available Format(s)
Catalogue Number
QAP044123_1 QAP044123_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Transplantation (Viral)
Feature
Available Format(s)
Catalogue Number
QAM174198_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Torque teno virus
Feature
Available Format(s)
Catalogue Number
QAV184203_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q4
Multiple Pathogen / Syndromic
Click to view / hide
Bacterial Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAB124153_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Chlamydia trachomatis and Neisseria gonorrhoeae
Feature
Available Format(s)
Catalogue Number
QAB174191_1 QAB174191_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Central Nervous System I (Viral)
Feature
Available Format(s)
Catalogue Number
QAV174195_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Central Nervous System II (Non-Viral)
Feature
Available Format(s)
Catalogue Number
QAM174196_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Immunocompromised
Feature
Available Format(s)
Catalogue Number
QAM174197_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Neonatal / New-born infections
Feature
Available Format(s)
Catalogue Number
QAM174199_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Parasitic Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAP124154_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Respiratory I
Feature
Available Format(s)
Catalogue Number
QAV164188_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Respiratory II
Feature
Available Format(s)
Catalogue Number
QAV164189_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Respiratory III
Feature
Available Format(s)
Catalogue Number
QAM174193_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Sepsis
Feature
Available Format(s)
Catalogue Number
QAB164178_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Sexually Transmitted Infections I
Feature
Available Format(s)
Catalogue Number
QAB154177_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Sexually Transmitted Infections II
Feature
Available Format(s)
Catalogue Number
QAM174201_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Transplantation (Viral)
Feature
Available Format(s)
Catalogue Number
QAM174198_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Viral Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAV124152_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Respiratory Diseases
Click to view / hide
Adenovirus
Feature
Available Format(s)
Catalogue Number
QAV054133_1 QAV054133_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Bordetella pertussis
Feature
Available Format(s)
Catalogue Number
QAB094132_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Chlamydophila pneumoniae
Feature
Available Format(s)
Catalogue Number
QAB084107_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q2
Chlamydia psittaci
Feature
Available Format(s)
Catalogue Number
QAB134165_1
Total Number of Challenges
1
Number of Panel Members
8 to 10
Distribution / Testing Period
Q2
Coronavirus
Feature
Available Format(s)
Catalogue Number
QAV064137_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Human Metapneumovirus
Feature
Available Format(s)
Catalogue Number
QAV054135_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Influenza A & B virus
Feature
Available Format(s)
Catalogue Number
QAV054134_1 QAV054134_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Influenza Haemagglutinin Typing
Feature
Available Format(s)
Catalogue Number
QAV064138_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q4
Legionella pneumophila
Feature
Available Format(s)
Catalogue Number
QAB044122_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q1
Measles / Mumps
Feature
Available Format(s)
Catalogue Number
QAV144171_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
MERS Coronavirus
Feature
Available Format(s)
Catalogue Number
QAV154181_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q2
Mycobacterium tuberculosis
Feature
Available Format(s)
Catalogue Number
QAB014129_1 QAB014129_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Mycoplasma pneumoniae
Feature
Available Format(s)
Catalogue Number
QAB174192_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q2
Parainfluenza virus
Feature
Available Format(s)
Catalogue Number
QAV064136_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Pneumocystis jirovecii pneumonia (PCP)
Feature
Available Format(s)
Catalogue Number
QAF114144_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Respiratory Syncytial virus
Feature
Available Format(s)
Catalogue Number
QAV054142_1 QAV054142_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Rhinovirus
Feature
Available Format(s)
Catalogue Number
QAV064143_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Respiratory I
Feature
Available Format(s)
Catalogue Number
QAV164188_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Respiratory II
Feature
Available Format(s)
Catalogue Number
QAV164189_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Respiratory III
Feature
Available Format(s)
Catalogue Number
QAM174193_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Serology
Click to view / hide
Blood borne virus serology
Feature
Available Format(s)
Catalogue Number
QAS144172_2
Total Number of Challenges
2
Number of Panel Members
4 to 6 per challenge
Distribution / Testing Period
Q1 & Q3
Immune status serology
Feature
Available Format(s)
Catalogue Number
QAS144174_2
Total Number of Challenges
2
Number of Panel Members
4 to 6 per challenge
Distribution / Testing Period
Q1 & Q3
Viral hepatitis serology
Feature
Available Format(s)
Catalogue Number
QAS144173_2
Total Number of Challenges
2
Number of Panel Members
4 to 6 per challenge
Distribution / Testing Period
Q1 & Q3
Sexually Transmitted Infections
Click to view / hide
Chlamydia trachomatis
Feature
Available Format(s)
Catalogue Number
QAB004101_1 QAB004101_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Chlamydia trachomatis and Neisseria gonorrhoeae
Feature
Available Format(s)
Catalogue Number
QAB174191_1 QAB174191_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Herpes simplex virus 1 & 2
Feature
Available Format(s)
Catalogue Number
QAV994105_1 QAV994105_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Herpes Simplex virus drug resistance
Feature
Available Format(s)
Catalogue Number
QAV164184_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q1
Human Papillomavirus (PreservCyt)
Feature
Available Format(s)
Catalogue Number
QAV094130_1 QAV094130_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Human Papillomavirus (SurePath)
Feature
Available Format(s)
Catalogue Number
QAV184204_1 QAV184204_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Mycoplasma genitalium
Feature
Available Format(s)
Catalogue Number
QAB184205_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q3
Neisseria gonorrhoeae
Feature
Available Format(s)
Catalogue Number
QAB034126_1 QAB034126_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q1 & Q3
Sexually Transmitted Infections I
Feature
Available Format(s)
Catalogue Number
QAB154177_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Sexually Transmitted Infections II
Feature
Available Format(s)
Catalogue Number
QAM174201_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Syphilis
Feature
Available Format(s)
Catalogue Number
QAB154180_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q4
Trichomonas vaginalis
Feature
Available Format(s)
Catalogue Number
QAP184202_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q3
Transplant Associated Diseases
Click to view / hide
Adenovirus
Feature
Available Format(s)
Catalogue Number
QAV054133_1 QAV054133_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
BK virus
Feature
Available Format(s)
Catalogue Number
QAV144166_1 QAV144166_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
CMV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV144169_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q2
Cytomegalovirus Whole Blood
Feature
Available Format(s)
Catalogue Number
QAV124150_1 QAV124150_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Epstein-Barr virus
Feature
Available Format(s)
Catalogue Number
QAV024121_1 QAV024121_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Epstein-Barr virus Whole Blood
Feature
Available Format(s)
Catalogue Number
QAV134161_1 QAV134161_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Human Cytomegalovirus
Feature
Available Format(s)
Catalogue Number
QAV014120_1 QAV014120_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Human Herpes virus 6
Feature
Available Format(s)
Catalogue Number
QAV084119_1 QAV084119_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
JC virus
Feature
Available Format(s)
Catalogue Number
QAV074106_1 QAV074106_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q3 Q2 & Q3
Toxoplasma gondii
Feature
Available Format(s)
Catalogue Number
QAP044123_1 QAP044123_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Transplantation (Viral)
Feature
Available Format(s)
Catalogue Number
QAM174198_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Torque teno virus
Feature
Available Format(s)
Catalogue Number
QAV184203_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q4
Typing
Click to view / hide
Bacterial 16S Ribosomal RNA
Feature
Available Format(s)
Catalogue Number
QAB164183_1
Total Number of Challenges
1
Number of Panel Members
8 to 10
Distribution / Testing Period
Q4
CMV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV144169_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q2
Enterovirus Typing
Feature
Available Format(s)
Catalogue Number
QAV164185_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q1
HBV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV124160_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
HBV Genotyping
Feature
Available Format(s)
Catalogue Number
QAV064118_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q1
HCV Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV134167_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
HCV Genotyping
Feature
Available Format(s)
Catalogue Number
QAV034117_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q1
Herpes Simplex virus drug resistance
Feature
Available Format(s)
Catalogue Number
QAV164184_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q1
HIV-1 Drug Resistance
Feature
Available Format(s)
Catalogue Number
QAV024131_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
HIV-1 Drug Resistance (Integrase)
Feature
Available Format(s)
Catalogue Number
QAV114146_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q3
Influenza Haemagglutinin Typing
Feature
Available Format(s)
Catalogue Number
QAV064138_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q4
MALDI-TOF
Feature
Available Format(s)
Catalogue Number
QAB124155_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Methicillin Resistant Staphylococcus aureus Typing (epidemiology and outbreak studies)
Feature
Available Format(s)
Catalogue Number
QAB074128_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Staphylococcus aureus spa
Feature
Available Format(s)
Catalogue Number
QAB134164_1
Total Number of Challenges
1
Number of Panel Members
6 to 12
Distribution / Testing Period
Q2
EQA Pilot Studies
Click to view / hide
Bacterial 16S Ribosomal RNA
Feature
Available Format(s)
Catalogue Number
QAB164183_1
Total Number of Challenges
1
Number of Panel Members
8 to 10
Distribution / Testing Period
Q4
Bacterial Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAB124153_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Central Nervous System I (Viral)
Feature
Available Format(s)
Catalogue Number
QAV174195_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Central Nervous System II (Non-Viral)
Feature
Available Format(s)
Catalogue Number
QAM174196_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Dermatophytosis
Feature
Available Format(s)
Catalogue Number
QAF164187_1
Total Number of Challenges
1
Number of Panel Members
8 to 10
Distribution / Testing Period
Q3
Diarrheagenic Escherichia coli
Feature
Available Format(s)
Catalogue Number
QAB154179_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Enterovirus Typing
Feature
Available Format(s)
Catalogue Number
QAV164185_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q1
Extended Spectrum ß-lactamase and Carbapenemase
Feature
Available Format(s)
Catalogue Number
QAB134162_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Group B Streptococcus
Feature
Available Format(s)
Catalogue Number
QAB174200_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Helicobacter pylori
Feature
Available Format(s)
Catalogue Number
QAB164190_1
Total Number of Challenges
1
Number of Panel Members
5 to 10
Distribution / Testing Period
Q3
Herpes Simplex virus drug resistance
Feature
Available Format(s)
Catalogue Number
QAV164184_1
Total Number of Challenges
1
Number of Panel Members
4 to 7
Distribution / Testing Period
Q1
Immunocompromised
Feature
Available Format(s)
Catalogue Number
QAM174197_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
MALDI-TOF
Feature
Available Format(s)
Catalogue Number
QAB124155_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Neonatal / New-born infections
Feature
Available Format(s)
Catalogue Number
QAM174199_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Parasitic Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAP124154_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Respiratory I
Feature
Available Format(s)
Catalogue Number
QAV164188_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Respiratory II
Feature
Available Format(s)
Catalogue Number
QAV164189_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
Respiratory III
Feature
Available Format(s)
Catalogue Number
QAM174193_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Sepsis
Feature
Available Format(s)
Catalogue Number
QAB164178_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Sexually Transmitted Infections I
Feature
Available Format(s)
Catalogue Number
QAB154177_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Sexually Transmitted Infections II
Feature
Available Format(s)
Catalogue Number
QAM174201_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Transplantation (Viral)
Feature
Available Format(s)
Catalogue Number
QAM174198_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Vancomycin Resistant Enterococci
Feature
Available Format(s)
Catalogue Number
QAB134163_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q3
Viral Gastroenteritis
Feature
Available Format(s)
Catalogue Number
QAV124152_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Zika virus
Feature
Available Format(s)
Catalogue Number
QAV164186_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q2
New EQA Pilot Studies
Click to view / hide
Human Papillomavirus (SurePath)
Feature
Available Format(s)
Catalogue Number
QAV184204_1 QAV184204_2
Total Number of Challenges
1 2
Number of Panel Members
8 to 12 4 to 6 per challenge
Distribution / Testing Period
Q4 Q2 & Q4
Mycoplasma genitalium
Feature
Available Format(s)
Catalogue Number
QAB184205_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q3
Torque teno virus
Feature
Available Format(s)
Catalogue Number
QAV184203_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q4
Trichomonas vaginalis
Feature
Available Format(s)
Catalogue Number
QAP184202_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q3
Other
Click to view / hide
Dermatophytosis
Feature
Available Format(s)
Catalogue Number
QAF164187_1
Total Number of Challenges
1
Number of Panel Members
8 to 10
Distribution / Testing Period
Q3
Group B Streptococcus
Feature
Available Format(s)
Catalogue Number
QAB174200_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Mycoplasma spp. (cell contamination)
Feature
Available Format(s)
Catalogue Number
QAB144168_1
Total Number of Challenges
1
Number of Panel Members
8 to 12
Distribution / Testing Period
Q4
Torque teno virus
Feature
Available Format(s)
Catalogue Number
QAV184203_1
Total Number of Challenges
1
Number of Panel Members
6 to 10
Distribution / Testing Period
Q4

Unit 5, Technology Terrace, Todd Campus, West of Scotland Science Park Glasgow G20 0XA Scotland, UK
Tel: +44 (0)141 945 6474 Fax: +44 (0)141 945 5795 Contact Us